{"transactions":[{"id":2117639,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":122418,"kind":"person","name":"Girard Armand","position":1,"cik":"0001769636","reported_name":"Girard Armand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2022-11-14T21:04:18.000Z","date":"2022-11-11","kind":"purchase","acquired":true,"shares":6500,"price":1.05,"value":6825.0,"ownership":{"direct":true},"balance_after":29161,"source":{"system":"sec-edgar","filing":"0001209191-22-056563","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000120919122056563/doc4.xml","form_type":"4"}},{"id":2339530,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":122418,"kind":"person","name":"Girard Armand","position":1,"cik":"0001769636","reported_name":"Girard Armand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2022-03-10T22:05:07.000Z","date":"2022-03-09","kind":"sale","acquired":false,"shares":2339,"price":1.09,"value":2549.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected to satisfy tax withholding obligations in connection with the settlement of restricted stock units as part of a \"sell to cover\" transaction and do not represent discretionary trades by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The common stock was sold by the reporting person in a series of open market transactions on the transaction date with a volume weighted average sale price of $1.09. The range of sales prices for the transactions reported was $1.09 to $1.11 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":22661,"source":{"system":"sec-edgar","filing":"0001209191-22-017968","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000120919122017968/doc4.xml","form_type":"4"}},{"id":2426501,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":122418,"kind":"person","name":"Girard Armand","position":1,"cik":"0001769636","reported_name":"Girard Armand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-01-26T02:02:16.000Z","date":"2022-01-21","kind":"grant","acquired":true,"shares":47700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"50% of the shares underlying this option will vest upon FDA approval of the Issuer's product candidate uproleselan as a treatment for relapsed/refractory acute myeloid leukemia and the remainder will vest upon the first commercial sale of uproleselan in the United States or abroad, subject in each case to the Reporting Person's continued service with the Issuer through the applicable vesting date."}],"balance_after":47700,"derivative":{"exercise_price":1.11,"expiration_date":"2032-01-20","underlying":"Common Stock","underlying_shares":47700},"source":{"system":"sec-edgar","filing":"0001209191-22-004896","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000120919122004896/doc4.xml","form_type":"4"}},{"id":2426500,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":122418,"kind":"person","name":"Girard Armand","position":1,"cik":"0001769636","reported_name":"Girard Armand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-01-26T02:02:16.000Z","date":"2022-01-21","kind":"grant","acquired":true,"shares":144700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this option will vest on January 21, 2023 and the remaining underlying shares will vest in equal monthly installments over 36 months thereafter, subject to the Reporting Person's continued service with the Issuer through each such vesting date."}],"balance_after":144700,"derivative":{"exercise_price":1.11,"expiration_date":"2032-01-20","underlying":"Common Stock","underlying_shares":144700},"source":{"system":"sec-edgar","filing":"0001209191-22-004896","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000120919122004896/doc4.xml","form_type":"4"}},{"id":2898925,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":122418,"kind":"person","name":"Girard Armand","position":1,"cik":"0001769636","reported_name":"Girard Armand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-01-22T21:07:15.000Z","date":"2021-01-20","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares underlying this option vest on January 20, 2022 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":50000,"derivative":{"exercise_price":3.81,"expiration_date":"2031-01-19","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-21-004850","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000120919121004850/doc4.xml","form_type":"4"}},{"id":2898924,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":122418,"kind":"person","name":"Girard Armand","position":1,"cik":"0001769636","reported_name":"Girard Armand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-01-22T21:07:15.000Z","date":"2021-01-20","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The security represents restricted stock units granted to the reporting person. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"25% of these restricted stock units vest on each of January 20, 2022, 2023, 2024 and 2025, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001209191-21-004850","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000120919121004850/doc4.xml","form_type":"4"}},{"id":3302648,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":122418,"kind":"person","name":"Girard Armand","position":1,"cik":"0001769636","reported_name":"Girard Armand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-01-24T21:23:21.000Z","date":"2020-01-22","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of the shares underlying this option vest on January 22, 2021 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date."}],"balance_after":100000,"derivative":{"exercise_price":4.72,"expiration_date":"2030-01-21","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-20-004828","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000120919120004828/doc4.xml","form_type":"4"}}]}